Angiogenesis New Targets for the Development of Anticancer Chemotherapies

E-ISSN： 1873-4286|6|4|417-439

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.4, 2000-03, pp. : 417-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The p53-Mdm2 Pathway: Targets for the Development of New Anticancer Therapeutics

Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-05 ,pp. : 257-270

Bentham Science Publishers

Access to resources Recommend Favorite

Development of New Drugs in Angiogenesis

Current Drug Targets, Vol. 5, Iss. 5, 2004-07 ,pp. : 485-493

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 241-253

Bentham Science Publishers

Access to resources Recommend Favorite

Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?

Current Cancer Drug Targets, Vol. 6, Iss. 2, 2006-01 ,pp. : 147-180

Bentham Science Publishers

Access to resources Recommend Favorite

New potential targets for antifungal development

By Wills E.A. Redinbo M.R. Perfect J.R. Poeta M.D.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 3, 2000-06 ,pp. : 265-296

Informa Healthcare

Access to resources Recommend Favorite